Predictive factors for responses to primary medical treatment with lanreotide autogel 120 mg in acromegaly: post hoc analyses from the PRIMARYS study.
Stephan PetersennAude HouchardCaroline SertPhilippe J Caronnull nullPublished in: Pituitary (2021)
The use of predictive factors at baseline and week 12 of treatment could inform clinical expectations of the long-term efficacy of lanreotide autogel.
Keyphrases